Macro partitioning
Adjuvant chemotherapy causes sarcopenic obesity, characterized by increased fat mass and decreased or stagnant lean body mass, particularly in the legs.
Chemotherapy often causes 'sarcopenic obesity,' where you gain fat but lose muscle, especially in your legs. This is different from normal weight gain. To counteract this, prioritize resistance training (strength exercises) for your lower body to preserve muscle mass, rather than just focusing on the number on the scale.
In contrast, women in the CT group experienced increases in fat mass and percentage of body fat and decreases in leg lean body mass.
Why this rating
Measured by DEXA, a gold standard for body composition, with statistically significant differences in fat and lean mass changes.
Source
Changes in Weight, Body Composition, and Factors Influencing Energy Balance Among Premenopausal Breast Cancer Patients Receiving Adjuvant Chemotherapy
Wendy Demark‐Wahnefried et al. · Journal of Clinical Oncology · 2001
This is one finding among thousands. Every one is graded and traced to its source, so you can see what the evidence actually supports. Browse the research →